无偿献血者健康检查标准的国内外比较*

doi:10.3969/j.issn.1671-2587.2021.01.030

临床输血与检验 ›› 2021, Vol. 23 ›› Issue (1): 116-122.DOI: 10.3969/j.issn.1671-2587.2021.01.030

无偿献血者健康检查标准的国内外比较^*

李萌, 赵玉伟, 李莹, 魏习薇, 谭茜茜, 傅雪梅

610041 成都,成都市血液中心血液研究室

收稿日期:2020-06-19 发布日期:2021-02-22
通讯作者: 傅雪梅,女,重庆人,主任技师,主要从事采供血与管理工作,(E-mail）xuemeifucdbc@163.com。
作者简介:李萌（1986-）,女,河南南阳人,助理研究员,博士,输血医学相关研究,（Tel）15198218724,(E-mail）limeng226@163.com
基金资助:
*本课题受成都市医学科研课题（No. 2019093）资助

Received:2020-06-19 Published:2021-02-22

摘要/Abstract

摘要： 安全、充足、有效的血液供应是确保临床医疗救治和保障患者生命安全的重要支撑。科学、合理的献血者健康检查标准的制定及实施不仅保护献血者与受血者安全,而且可避免对献血者实施不必要的限制,以免影响血液供应的充足性。由于缺乏充分、系统的研究证据支撑,目前各国的献血者健康检查标准存在较大差异。本文通过综合中国、美国、日本、澳大利亚、加拿大、欧盟等国内外献血者健康检查标准及相关研究,期望为今后献血者健康检查标准的进一步修订和完善提供参考。

中图分类号:

R457

李萌, 赵玉伟, 李莹, 魏习薇, 谭茜茜, 傅雪梅. 无偿献血者健康检查标准的国内外比较^*[J]. 临床输血与检验, 2021, 23(1): 116-122.

参考文献

[1] WHO.Blood safety and availability[EB/OL].(2020-06-10).https://www.who.int/news-room/fact-sheets/detail/blood-safety-and-availability.
[2] EDER A,GOLDMAN M,ROSSMANN S,et al.Selection criteria to protect the blood donor in north America and Europe:past (dogma),present (evidence),and future (hemovigilance)[J].Transfus Med Rev,2009,23(3):205-220.
[3] 张美萍.陈书芳.周秀英.等. 浅谈如何做好暂缓延期献血者的招募[J]. 临床输血与检验,2010,12(4):354-355.
[4] SHI L,WANG J X,LIU Z,et al.Blood donor management in China[J].Transfus Med Hemother,2014,41(4):273-282.
[5] WHO.Blood donor selection:guidelines on assessing donor suitability for blood donation[EB/OL].(2012). https://apps.who.int/iris/handle/10665/76724.
[6] LEVITT J.Standards for blood banks and transfusion services[M].29th Edition.,Bethesda,AABB,2014.
[7] MOLONEY W C,LONNERGAN L R,MCCLINTOCK J K.Syncope in blood donors[J].N Engl J Med,1946,234(4):114-118.
[8] NEWMAN B H,SATZ S L,JANOWICZ N M,et al.Donor reactions in high-school donors:the effects of sex,weight,and collection volume[J].Transfusion,2006,46(2):284-288.
[9] EDER A F.Adverse reactions to allogeneic whole blood donation by 16-and 17-year-olds[J].JAMA,2008,299(19):2279.
[10] NISHIMORI H,FUJII N,FUJII K,et al.Predictors of vasovagal reactions during preoperative autologous blood donation:a single-institution analysis[J].Int J Hematol,2017,105(6):812-818.
[11] GOLDMAN M,OSMOND L,YI Q L,et al.Frequency and risk factors for donor reactions in an anonymous blood donor survey[J].Transfusion,2013,53(9):1979-1984.
[12] SALVADORI U,SANDRI M,CEMIN R,et al.Effect of a liberal versus a restrictive pre-donation blood pressure policy on whole-blood donor adverse reactions[J].Vox Sang,2019,114(4):317-324.
[13] FRANCE C R,FRANCE J L.Estimating the risk of blood donation fainting for self versus others:the mod-erating effect of fear[J].Transfusion,2019,59(6):2039-2045.
[14] 张燕华,戴梓宁,王同显.延长法定献血年龄的安全性和可行性[J].中国输血杂志,2020,33(2):172-175.
[15] EDER A F,DY B A,KENNEDY J M,et al.The American Red Cross donor hemovigilance program:complications of blood donation reported in 2006[J].Transfusion,2008,48(9):1809-1819.
[16] SHEHATA N,KUSANO R,HANNACH B,et al.Reacti-on rates in allogeneic donors[J].Transfus Med,2004, 14(5):327-333.
[17] TAKANASHI M,ODAJIMA T,AOTA S,et al.Risk factor analysis of vasovagal reaction from blood donation[J].Transfus Apher Sci,2012,47(3):319-325.
[18] ZEILER T,LANDER-KOX J,ALT T.Blood donation by elderly repeat blood donors[J].Transfus Med Hemotherapy,2014,41(4):242-250.
[19] GOLDMAN M,GERMAIN M,GRÉGOIRE Y,et al.Safety of blood donation by individuals over age 70 and their contribution to the blood supply in five developed countries:a BEST Collaborative group study[J].Transfusion,2019,59(4):1267-1272.
[20] WILTBANK T B,GIORDANO G F,KAMEL H,et al.Faint and prefaint reactions in whole-blood donors:an analysis of predonation measurements and their predictive value[J].Transfusion,2008,48(9):1799-1808.
[21] THIJSEN A,MASSER B.Vasovagal reactions in blood donors:risks,prevention and management[J].Transfus Med,2017,29:13-22.
[22] RIGA A,SAPEY T,BACANU M,et al.Blood donors- Serious adverse reactions(SAR)2010-2014 EFS Châteauroux,France[J].Transfus Clinique et Biol,2015,22(2):62-65.
[23] TONDON R,PANDEY P,CHAUDHARY R.Vasovagal reactions in 'at risk' donors:a univariate analysis of effect of age and weight on the grade of donor reactions[J].Transfus Apher Sci,2008,39(2):95-99.
[24] WIERSUM-OSSELTON J C,MARIJT-VAN DER KREEK T,BRAND A,et al.Risk factors for complications in donors at first and repeat whole blood donation:a cohort study with assessment of the impact on donor return[J].Blood Transfus,2014,12 Suppl 1:s28-s36.
[25] EDER A,KAMEL H,FRANCE C,et al,Appendix 1 Recommendations to minimize the risk of reactions and injuries amongadolescent blood donors[C]. Bethesda,MD,AABB:2008.
[26] EDER A F,DY B A,KENNEDY J M,et al.Improved safety for young whole blood donors with new selection criteria for total estimated blood volume[J].Transfusion,2011,51(7):1522-1531.
[27] PEREZ G E,GAMMON R R,WHITAKER B I,et al.Impact of changes to donor hemoglobin criteria on the rate of donor deferral[J].Transfusion,2018,58(11):2581-2588.
[28] OFFICE OF THE FEDERAL REGISTER,NATIONAL ARCHIVES AND RECORDS ADMINISTRATION. Requirements for blood and blood components intended for transfusion or for further manufacturing use[EB/OL].(2015-05-22). https://www.govinfo.gov/app/details/FR-2015-05-22/2015-12228.
[29] BEUTLER E,WAALEN J.The definition of anemia:what is the lower limit of normal of the blood hemoglobin concentration?[J].Blood,2006,107(5):1747-1750.
[30] PI D W,KRIKLER S H,SPARLING T G,et al.Reappraisal of optimal hemoglobin standards for female blood donors in Canada[J].Transfusion,1994,34(1):7-10.
[31] GAMMON R R,KOZEL T,MOREL P,et al.Evaluation of iron stores by zinc protoporphyrin analysis in blood donors[J].Lab Med,2018,49(4):311-315.
[32] GYBEL-BRASK M,SEEBERG J,THOMSEN L L,et al.Intravenous iron isomaltoside improves hemoglobin concentration and iron stores in female iron-deficient blood donors:a randomized double-blind placebo-controlled clinical trial[J].Transfusion,2018,58(4):974-981.
[33] SIMON T L.Iron stores in blood donors[J].JAMA:J Am Med Assoc,1981,245(20):2038.
[34] BAART A M,VAN DEN HURK K,DE KORT W L A M.Minimum donation intervals should be reconsidered to decrease low hemoglobin deferral in whole blood donors:an observational study[J].Transfusion,2015,55(11):2641-2644.
[35] MANASCERO-GÓMEZ A R,BRAVO-ESPINOSA M,SOLANO-MURIEL K,et al.Influence of blood donation time intervals on ferritin and hemoglobin concentration[J].Transfus Apher Sci,2015,53(2):213-219.
[36] SCHOTTEN N,PASKER-DE JONG P C M,MORETTI D,et al.The donation interval of 56 days requires extension to 180 days for whole blood donors to recover from changes in iron metabolism[J].Blood,2016,128(17):2185-2188.
[37] OFFICE OF THE FEDERAL REGISTER, NATIONAL ARCHIVES AND RECORDS ADMINISTRATION.Requirements for Human Blood and Blood Components Intended for Transfusion or for Further Manufacturing Use[EB/OL].(2007-11-08). https://www.govinfo.gov/app/details/FR-2007-11-08/E7-21565.
[38] Atherosclerosis,Hypertension,and Obesity in the Young Committee of the American Heart Association Council on Cardiovascular Disease in the Young,ALPERT B,MCCRINDLE B,et al.Recommend-ations for blood pressure measurement in humanAtherosclerosis,Hypertension,and Obesity in the Young Committee of the American Heart Association Council on Cardiovascular Disease in the Young,ALPERT B,MCCRINDLE B,Recommend-ations for blood pressure measurement in human and experimental animals;part 1:blood pressure measurement in humans[J]. Hypertension,2006;48:e3; author reply e5.
[39] ARAM V CHOBANIAN,GEORGE L BAKRIS, HEN-RY R BLACK,et al.Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure[J]. Hypertension, 2003,42(6):1206-1252.
[40] TIERNEY W M.Quantifying risk of adverse clinical events with one set of vital signs among primary care patients with hypertension[J].Ann Fam Med,2004,2(3):209-217.
[41] GERMAIN M,DELAGE G,GRÉGOIRE Y,et al. Donation by donors with an atypical pulse rate does not increase the risk of cardiac ischaemic events[J].Vox Sang,2013,104(4):309-316.
[42] MANN M,SACKS H J,GOLDFINGER D.Safety of autologous blood donation prior to elective surgery for a variety of potentially ''high-risk'' patients[J].Transfusion,1983,23(3):229-232.
[43] KLAPPER E,PEPKOWITZ S H,CZER L,et al.Con-firmation of the safety of autologous blood donation by patients awaiting heart or lung transplantation:a controlled study using hemodynamic monitoring[J].J Thorac Cardiovasc Surg,1995,110(6):1594-1599.
[44] EDER A,BIANCO C.Screening blood donors:Scien ce,reason,and the donor history questionnaire[C]. Bethesda:American Association of Blood Banks; 2007,11-16.
[45] EDGREN G,HJALGRIM H,REILLY M,et al.Risk of cancer after blood transfusion from donors with subclinical cancer:a retrospective cohort study[J].Lancet,2007,369(9574):1724-1730.
[46] QIUPING GU,RYNE PAULOSE-RAM,CHARLES DILLON,et al.Antihypertensive Medication Use Among US Adults with Hypertension[J].Circulation,2006,113(2):213-221.
[47] GOLDMAN M,W-Y SHIH A,O'BRIEN SF,et al. Donor deferral policies for men who have sex with men: past, present and future[J]. Vox Sang. 2018,113(2):95-103.

无偿献血者健康检查标准的国内外比较^*

PDF

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价

关于本刊

作者中心

在线期刊

访问统计

联系我们

[1]	朱永明. 血液工作的总目标与当前的一些主要问题[J]. 临床输血与检验, 2021, 23(1): 6-10.
[2]	陈庆恺, 何子毅. 输血传播疟疾与血液安全[J]. 临床输血与检验, 2021, 23(1): 122-126.
[3]	杨俊鸿, 黄霞, 何涛, 李小红. 献血不良反应监测进展^*[J]. 临床输血与检验, 2020, 22(5): 556-560.
[4]	杨俊鸿, 胡文杰, 杨丹蓉, 何涛, 黄霞. 新型冠状病毒肺炎疫情期间献血相关血管迷走神经反应预防措施及监测效果分析[J]. 临床输血与检验, 2020, 22(4): 376-379.
[5]	严珺, 尹文, 张侃. 新型冠状病毒（SARS-CoV-2）对血液安全的影响^*[J]. 临床输血与检验, 2020, 22(3): 232-235.
[6]	王湘屏, 郭建波, 段荣, 王英. 衡阳地区无偿献血者核酸检测结果分析^*[J]. 临床输血与检验, 2018, 20(6): 563-565.
[7]	林俊填, 刘知华, 何其通, 杨富燕, 余玉婷, 伍伟健. 佛山地区无偿献血人群酶免联合核酸检测结果分析[J]. 临床输血与检验, 2018, 20(6): 569-571.
[8]	许四宏, 王佑春. HBV/HCV/HIV核酸血筛试剂的研究及应用进展^*[J]. 临床输血与检验, 2018, 20(6): 581-584.
[9]	刘红梅,路志浩. 阜阳市2014~2016年无偿献血者梅毒检测结果分析[J]. 临床输血与检验, 2018, 20(3): 259-260.
[10]	王远杰,刘家瑞,李红梅,胡伦,段莉. 浅谈电子配血应用中应重视的几个问题*[J]. 临床输血与检验, 2018, 20(3): 308-311.
[11]	王振兴, 张兆晴, 叶柱江, 苏柱安, 何子毅, 陈庆恺. 储血点建立前后血液供应对比分析[J]. 临床输血与检验, 2018, 20(2): 136-137.
[12]	李鹏, 郭毅. 亚甲蓝病毒灭活血浆中人细小病毒B19抗原、抗体的检测与分析^*[J]. 临床输血与检验, 2018, 20(1): 20-22.
[13]	纪蓉蓉, 张锡敏, 康娜. 无偿献血者血浆颜色异常的初步分析[J]. 临床输血与检验, 2017, 19(6): 553-555.
[14]	邓丽娟. 咸宁市无偿献血者ALT初筛与抗-HCV检测结果的分析[J]. 临床输血与检验, 2017, 19(5): 524-525.
[15]	胡婷婷, 李军. 亲友互助献血对单采血小板复检不合格率的影响^*[J]. 临床输血与检验, 2017, 19(4): 347-349.